A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ immunopathology specialist was awarded a prestigious Children’s Hospital Foundation grant.

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.